Procter & Gamble Health · NSE: PGHL · BSE: 500126
Q2 FY19 results · Jul–Sep 2018
Procter & Gamble Health reported revenue from operations of ₹226.15 crore and net profit of ₹52.33 crore for Q2 FY19 (Jul–Sep 2018), on a standalone basis.
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 226.15 | — | — | 220.29 | +2.7% |
| Other income | 6.07 | — | — | 5.77 | +5.2% |
| Total income | 232.22 | — | — | 226.06 | +2.7% |
| Profit before tax | 59.94 | — | — | 51.71 | +15.9% |
| Net profit for the period | 52.33 | — | — | 48.31 | +8.3% |
| EPS, basic (₹) | 31.52 | — | — | 29.10 | +8.3% |
| Net margin (%) | 23.1 | — | 21.9 |
Standalone
- Filed with BSE
- 03 Nov 2018, 14:28 IST
- Board meeting
- 30 Oct 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE